411. Early letters have been omitted here
for the sake of brevity. The following represents the main correspondence
during the period from late 1997 to date.
412. Letter to Helen Southworth MP of 27
has any research into autism been
commissioned by the DoH since the Newson research of 1994?
could the DoH confirm that no research
at all is being progressed through the DoH's Research and Development
Programme, nor through the Department's Policy Research Programme?
why does the DoH not co-operate with
the DEE on identifying the numbers of children that are "statemented"
for special educational needs, and on the proportion that is diagnosed
as being on the autistic spectrum, and in particular in analysing
why there has been a steep increase in SEN places?
413. Letter to Helen Southworth MP of 31 March
what details are there of current
DoH research into the causes of autism?
what is the Department's response
to Professor Pattison's call of 25 March 1998 for more research?
why have specific criticisms set
out in my letter of 24 October 1997 of the Swedish MMR study not
been addressed in subsequent correspondence?
what active progress is being made
in resolving issues of classification, diagnosis and other potential
areas of international statistical compatibility, as referred
to by the DoH in its letter of 19 March 1998, to assist in determining
whether there has been an underlying real increase in autism?
please provide clarification of various
inconsistent wordings in DoH literature/patient leaflets in relation
to warnings about vaccinating children that are sensitive to certain
414. Letter to Helen Southworth MP of 5
will the Department itemise all that
it is doing in response to the reported 1,600 children that may
have suffered autism etc following vaccination (this followed
questioning on ITN News on 5 May 1998 as to what the Department
was doing about these children, and the response of Sir Kenneth
Calman that "we are doing everything . . .")
415. Letter to Helen Southworth MP of 31
as it is acknowledged by the DoH
that there is under-reporting of levels of suspected adverse reactions,
are figures supplied to Members of Parliament etc factored up
to compensate for this?
416. Letter to Helen Southworth MP of 9
could the DoH summarise its research
programme for the past 10 years?
what element of this has been on
investigating the causes of autism?
417. Letter to Helen Southworth MP of 23
is the DoH aware of the study into
possible links between vaccination and autism being carried out
by Dr V Singh at Ann Arbor University?
has it actively sought further details
of Dr Singh's work?
418. Letter to Helen Southworth MP of 14
does the DoH ever actually monitor
local levels of compliance regarding accurate/complete keeping
of child health records, or complaints about non-compliance?
does the DoH monitor the adequacy
of what is kept?
is the non-recording of a batch number
(as in the case of Oliver Thrower) a serious failure, in the eyes
of the DoH headquarters?
is the disappearance of an entire
set of Health Visitor records (as applies in the case of Oliver
Thrower) a serious failure?
what does the "legal requirement"
status of the keeping of records actually mean in practice, and
who takes the action?
if patients' records have to be kept
for 25-26 years, and the EC Consumer Protection Act is effective
for 10 years after vaccination, why do manufacturers only have
to keep records for five or six years?
why is the recommendation of January
1997 of the House of Commons Health Committee regarding keeping
a database on autism now being dismissed by the present Government?
why is there no DoH headquarters-level
interest in the overall national prevalence of autism?
will the Minister specifically itemise
what is being done to investigate the causes of autism?
ditto regarding the prevalence of
what steps is the UK Government taking
to progress international/WHO agreement on SLD categories, to
facilitate statistical data-gathering?
which experts were invited to the
27 March 1997 Medical Research Council seminar?
why were other interested parties,
including parents' representatives, solicitors and Members of
Parliament, excluded from the seminar or not invited to it?
419. Letter to Helen Southworth MP of 20
seeking a response to further three
research papers forwarded to the DoH, particularly the Weibel
were any of these researchers invited
to the MRC review of 27 March 1997?
how many does were in each batch
of M/MMR vaccine pre and post 1998?
does Priorix contain the same ingredients
do these differ in makeup and amount?
does/did MMR contain myelin basic
protein and what were the results of any testing?
can confirmation of the amounts (if
any) of aluminium be given in M/MMR?
exactly how much notice was given
to Merck Sharpe Dohme of the discontinuation of the other two
supplies of MMR in September 1992, for them to make up the shortfall?
does the Department accept in principle
that brain damage can result from M or MMR vaccination?
was it Sir Kenneth Calman that personally
approved Pluserix and Imruvax in 1998-8?
who were the members of the JCVI
in 1987, 1988, and 1989?
420. The great majority of the above remain
wholly unanswered as at the beginning of June 1999. The Department
has made it clear that it is not going to offer any answers. In
consequence, the unanswered correspondence, and the unanswered
specific questions within it, have been referred to the Parliamentary
Ombudsman for investigation.